[
Learning Objectives
After viewing this program, participants will be better able to:
Summarize current/recommended nephrology guidelines in clinical practice
Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
Identify/integrate current therapeutic options for specific renal disorders
Review and interpret up-to-date literature relevant to clinical practice
Describe pathophysiological mechanisms as they apply to management of renal disease
Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations
ACGME Competencies
This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:
Patient Care and Procedural Skills
Medical Knowledge
Practice-Based Learning and Improvement
Target Audience
The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.
Topics And Speakers:
Glomerulonephritis
Renal Physiology for the Boards – Melanie P. Hoenig, MD
Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD
Renal Pathology in 2020: Part 1 – Helmut G. Rennke, MD
Renal Pathology in 2020: Part 2 – Astrid Weins, MD, PhD
Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD
IgA Nephropathy – Gerald B. Appel, MD
Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
ANCA Vasculitis – John L. Niles, MD
Update on Lupus Nephritis – Gerald B. Appel, MD
Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD
Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
Must-Know Board Zebra – Emily Robinson, MD, MPH
Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
Nephrology Board Review Practice 2 – Mallika Mendu, MD
Electrolytes and Acid Base
Workshop: Hyponatremia and Hypernatremia – David B. Mount, MD
Hypokalemia and Hyperkalemia – David B. Mount, MD
Acid-Base Part I – Acidosis – Alan S.L. Yu, MB, BChir
Acid-Base Part II – Alkalosis – Alan S.L. Yu, MB, BChir
COVID-19 and Kidney Disease – Daniel Batlle, MD
Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
Update on Polycystic Kidney Disease – Cristian Riella, MD
Pediatric Nephrology – Michael J.G. Somers, MD
Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH
Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 1 – Alan S.L. Yu, MB, BChir
Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 2 – Alan S.L. Yu, MB, BChir
Chronic Kidney Disease in the Community: Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP
Transplantation
Why Do We Reject a Transplant? – Jamil R. Azzi, MD
Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
Early Post-Transplant Management – Anil K. Chandraker, MD
Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD
Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD
Infections in Transplant Recipients – Sarah P. Hammond, MD
COVID-19 and Transplant Patients – Enver Akalin, MD, FAST, FASN
Renal Transplant Recipient Medical Evaluation – Jamil R. Azzi, MD
Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS
Donor Evaluation – Kassem Safa, MD
Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
Thrombotic Microangiopathies – Jean M. Francis, MD
Geriatric Nephrology – Ernest I. Mandel, MD
Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD, and Edgar L. Milford, MD
Transplant Board Review – Leonardo V. Riella, MD, PhD
CKD and General Nephrology
Update on Renovascular Disease – Joseph M. Garasic, MD
Management of Hypertension after SPRINT – Richard J. Glassock, MD
Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
Liver and the Kidney – Andrew S. Allegretti, MD, MSc
Acute Kidney Injury
Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
Acute Kidney Injury Syndromes – Alice Sheridan, MD
ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
COVID-19 in the ICU – Jeremy B. Richards, MD
Cancer and Acute Kidney Injury – Albert Q. Lam, MD
Paraprotein Induced Kidney Injury – Albert Q. Lam, MD
FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD
Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH
APOL1 and Kidney Disease – Martin R. Pollak, MD
Dialysis
Dialysis Dosing – J. Kevin Tucker, MD
Mineral and Bone Disease – David Bushinsky, MD
Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
Pearls in Mineral and Bone Disease – David Bushinsky, MD
Chronic Kidney Disease Epidemiology: A 2019 Update – Gearoid M. McMahon, MB BCh
Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
COVID-19 and Patients on Dialysis – Giuliano Brunori, MD
Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
]